药 物 回 收
|
| |
| Canada: Recall: Votrient: The dissolution is out of specification in the affected lot (English only) |
| |
Health Canada announces that Novartis Pharmaceuticals Canada Inc. is recalling one lot of Votrient Tablet 200mg (pazopanib) (lot number: MJ5389) from retailers because the dissolution is out of specification in the affected lot.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/votrient-dissolution-out-specification-affected-lot
In Hong Kong, Votrient Tab 200mg (HK-60351), Votrient Tab 200mg (Spain) (HK-62096) and Votrient Tablets 200mg (HK-67932) are pharmaceutical products registered by Novartis Pharmaceuticals (HK) Limited (Novartis). All products are prescription-only medicines. As confirmed with Novartis, the affected lot has not been imported into Hong Kong.
Ends/Friday, Nov 17, 2023
Issued at HKT 16:00
|
| |
